High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies

Objective: We assessed the association between thyroid autoimmunity and thyroid cancer in a retrospective series of unselected thyroid nodules submitted to fine-needle aspiration cytology (FNAC) to avoid the selection bias of surgical series. Subjects and methods: Ultrasound (US)-guided FNACs were o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of endocrinology 2005-11, Vol.153 (5), p.637-642
Hauptverfasser: Boi, F, Lai, M L, Marziani, B, Minerba, L, Faa, G, Mariotti, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 642
container_issue 5
container_start_page 637
container_title European journal of endocrinology
container_volume 153
creator Boi, F
Lai, M L
Marziani, B
Minerba, L
Faa, G
Mariotti, S
description Objective: We assessed the association between thyroid autoimmunity and thyroid cancer in a retrospective series of unselected thyroid nodules submitted to fine-needle aspiration cytology (FNAC) to avoid the selection bias of surgical series. Subjects and methods: Ultrasound (US)-guided FNACs were obtained from 590 unselected consecutive patients with single thyroid nodules and positive (ATA + , n = 197) or negative (ATA − , n = 393) serum anti-thyroid antibody (ATA). Cytological results were classified in three classes of increased risk of malignancy: low risk or benign (class II); indeterminate risk (class III); and suspect or malignant (class IV). Results: A higher prevalence of class III (28.9% vs 21.4%, P < 0.05) and class IV (18.8% vs 9.2%, P < 0.001) and lower prevalence of class II (52.3% vs 69.5%, P < 0.001) were found in ATA + vs ATA − nodules respectively. By multivariate logistic regression analysis ATA + conferred a significant risk (odds ratio (OR): 2.29 (95% confidence interval (CI): 1.39–3.76)) for class IV cytology independently from age and sex. In 106 patients where thyroidectomy was carried out, thyroid cancer was found in 54/61 (88.5%) patients with class IV nodules (with similar positive predictive value for cancer in ATA + (96.4%) and ATA– (81.8%) nodules), in 6/31 (19.3%) of class III nodules (all ATA − ) and in none of 14 class II nodules. Non-specific cytological atypias from hyperplastic nodules in lymphocytic thyroiditis probably accounted for the different prevalence of cancer in class III ATA + and ATA − nodules. Histologically proven thyroid cancer (mostly papillary) was then observed in a higher proportion (27/197 = 13.7%) of ATA + , when compared with ATA − nodules (33/393 = 8.4%, P = 0.044), but the significance of this finding is limited by the low number of class II nodules operated on. Conclusions: The presence of ATA + confers an increased risk of suspicious or malignant cytology in unselected thyroid nodules. Since ATA + is not responsible for increased false- positive class IV FNAC, our study provides indirect evidence supporting a significant association between thyroid carcinoma and thyroid autoimmunity, although further studies with a different design are needed for a definitive histological proof.
doi_str_mv 10.1530/eje.1.02020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68741331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68741331</sourcerecordid><originalsourceid>FETCH-LOGICAL-b456t-9d0c3b879be88dc1abc0a8dd74cb48060550efe2669af3d10bed02408a63aea93</originalsourceid><addsrcrecordid>eNqF0UFv1DAQBWALgehSOHFHvsAFZbFjx3GOqAKKVIkLSNyisT1pp8rGSyZptf8el13RG8iH8eHTszxPiNdabXVj1Ae8xa3eqrqcJ2KjbdtVzpufT8VGeWUr66w5Ey-Yb5XS5a6eizPtaqdsrTeCLun6Ru5nvIMRp4gyD5JX3lOkvLKMhyWP-fogaZLLzWHOlOSU0zoiS2DOkWDBJO9pKSGZaaE7_AthXTJMC4WcCPmleDbAyPjqNM_Fj8-fvl9cVlffvny9-HhVBdu4peqSiib4tgvofYoaQlTgU2ptDNYrp5pG4YC1cx0MJmkVMKnaKg_OAEJnzsW7Y-5-zr9W5KXfEUccR5iwfKl3vrXaGP1fqDura-8f4PsjjHNmnnHo9zPtYD70WvUPFfSlgl73fyoo-s0pdg07TI_2tPMC3p4AcIRxmGGKxI-urRvXdbY4fXSBMkfCssmBIvzz8d86MKIM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19412881</pqid></control><display><type>article</type><title>High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies</title><source>MEDLINE</source><source>Oxford Academic Journals (OUP)</source><creator>Boi, F ; Lai, M L ; Marziani, B ; Minerba, L ; Faa, G ; Mariotti, S</creator><creatorcontrib>Boi, F ; Lai, M L ; Marziani, B ; Minerba, L ; Faa, G ; Mariotti, S</creatorcontrib><description>Objective: We assessed the association between thyroid autoimmunity and thyroid cancer in a retrospective series of unselected thyroid nodules submitted to fine-needle aspiration cytology (FNAC) to avoid the selection bias of surgical series. Subjects and methods: Ultrasound (US)-guided FNACs were obtained from 590 unselected consecutive patients with single thyroid nodules and positive (ATA + , n = 197) or negative (ATA − , n = 393) serum anti-thyroid antibody (ATA). Cytological results were classified in three classes of increased risk of malignancy: low risk or benign (class II); indeterminate risk (class III); and suspect or malignant (class IV). Results: A higher prevalence of class III (28.9% vs 21.4%, P &lt; 0.05) and class IV (18.8% vs 9.2%, P &lt; 0.001) and lower prevalence of class II (52.3% vs 69.5%, P &lt; 0.001) were found in ATA + vs ATA − nodules respectively. By multivariate logistic regression analysis ATA + conferred a significant risk (odds ratio (OR): 2.29 (95% confidence interval (CI): 1.39–3.76)) for class IV cytology independently from age and sex. In 106 patients where thyroidectomy was carried out, thyroid cancer was found in 54/61 (88.5%) patients with class IV nodules (with similar positive predictive value for cancer in ATA + (96.4%) and ATA– (81.8%) nodules), in 6/31 (19.3%) of class III nodules (all ATA − ) and in none of 14 class II nodules. Non-specific cytological atypias from hyperplastic nodules in lymphocytic thyroiditis probably accounted for the different prevalence of cancer in class III ATA + and ATA − nodules. Histologically proven thyroid cancer (mostly papillary) was then observed in a higher proportion (27/197 = 13.7%) of ATA + , when compared with ATA − nodules (33/393 = 8.4%, P = 0.044), but the significance of this finding is limited by the low number of class II nodules operated on. Conclusions: The presence of ATA + confers an increased risk of suspicious or malignant cytology in unselected thyroid nodules. Since ATA + is not responsible for increased false- positive class IV FNAC, our study provides indirect evidence supporting a significant association between thyroid carcinoma and thyroid autoimmunity, although further studies with a different design are needed for a definitive histological proof.</description><identifier>ISSN: 0804-4643</identifier><identifier>EISSN: 1479-683X</identifier><identifier>DOI: 10.1530/eje.1.02020</identifier><identifier>PMID: 16260421</identifier><language>eng</language><publisher>Colchester: European Society of Endocrinology</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Autoantibodies - blood ; Biological and medical sciences ; Clinical Studies ; Endocrinopathies ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Male ; Medical sciences ; Middle Aged ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Retrospective Studies ; Risk Assessment ; Thyroid Gland - immunology ; Thyroid Neoplasms - etiology ; Thyroid Nodule - complications ; Thyroid Nodule - diagnostic imaging ; Thyroid Nodule - immunology ; Thyroid Nodule - pathology ; Thyroid. Thyroid axis (diseases) ; Ultrasonography ; Vertebrates: endocrinology</subject><ispartof>European journal of endocrinology, 2005-11, Vol.153 (5), p.637-642</ispartof><rights>2005 Society of the European Journal of Endocrinology</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b456t-9d0c3b879be88dc1abc0a8dd74cb48060550efe2669af3d10bed02408a63aea93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17256994$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16260421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boi, F</creatorcontrib><creatorcontrib>Lai, M L</creatorcontrib><creatorcontrib>Marziani, B</creatorcontrib><creatorcontrib>Minerba, L</creatorcontrib><creatorcontrib>Faa, G</creatorcontrib><creatorcontrib>Mariotti, S</creatorcontrib><title>High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies</title><title>European journal of endocrinology</title><addtitle>eur j endocrinol</addtitle><description>Objective: We assessed the association between thyroid autoimmunity and thyroid cancer in a retrospective series of unselected thyroid nodules submitted to fine-needle aspiration cytology (FNAC) to avoid the selection bias of surgical series. Subjects and methods: Ultrasound (US)-guided FNACs were obtained from 590 unselected consecutive patients with single thyroid nodules and positive (ATA + , n = 197) or negative (ATA − , n = 393) serum anti-thyroid antibody (ATA). Cytological results were classified in three classes of increased risk of malignancy: low risk or benign (class II); indeterminate risk (class III); and suspect or malignant (class IV). Results: A higher prevalence of class III (28.9% vs 21.4%, P &lt; 0.05) and class IV (18.8% vs 9.2%, P &lt; 0.001) and lower prevalence of class II (52.3% vs 69.5%, P &lt; 0.001) were found in ATA + vs ATA − nodules respectively. By multivariate logistic regression analysis ATA + conferred a significant risk (odds ratio (OR): 2.29 (95% confidence interval (CI): 1.39–3.76)) for class IV cytology independently from age and sex. In 106 patients where thyroidectomy was carried out, thyroid cancer was found in 54/61 (88.5%) patients with class IV nodules (with similar positive predictive value for cancer in ATA + (96.4%) and ATA– (81.8%) nodules), in 6/31 (19.3%) of class III nodules (all ATA − ) and in none of 14 class II nodules. Non-specific cytological atypias from hyperplastic nodules in lymphocytic thyroiditis probably accounted for the different prevalence of cancer in class III ATA + and ATA − nodules. Histologically proven thyroid cancer (mostly papillary) was then observed in a higher proportion (27/197 = 13.7%) of ATA + , when compared with ATA − nodules (33/393 = 8.4%, P = 0.044), but the significance of this finding is limited by the low number of class II nodules operated on. Conclusions: The presence of ATA + confers an increased risk of suspicious or malignant cytology in unselected thyroid nodules. Since ATA + is not responsible for increased false- positive class IV FNAC, our study provides indirect evidence supporting a significant association between thyroid carcinoma and thyroid autoimmunity, although further studies with a different design are needed for a definitive histological proof.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Autoantibodies - blood</subject><subject>Biological and medical sciences</subject><subject>Clinical Studies</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Thyroid Gland - immunology</subject><subject>Thyroid Neoplasms - etiology</subject><subject>Thyroid Nodule - complications</subject><subject>Thyroid Nodule - diagnostic imaging</subject><subject>Thyroid Nodule - immunology</subject><subject>Thyroid Nodule - pathology</subject><subject>Thyroid. Thyroid axis (diseases)</subject><subject>Ultrasonography</subject><subject>Vertebrates: endocrinology</subject><issn>0804-4643</issn><issn>1479-683X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0UFv1DAQBWALgehSOHFHvsAFZbFjx3GOqAKKVIkLSNyisT1pp8rGSyZptf8el13RG8iH8eHTszxPiNdabXVj1Ae8xa3eqrqcJ2KjbdtVzpufT8VGeWUr66w5Ey-Yb5XS5a6eizPtaqdsrTeCLun6Ru5nvIMRp4gyD5JX3lOkvLKMhyWP-fogaZLLzWHOlOSU0zoiS2DOkWDBJO9pKSGZaaE7_AthXTJMC4WcCPmleDbAyPjqNM_Fj8-fvl9cVlffvny9-HhVBdu4peqSiib4tgvofYoaQlTgU2ptDNYrp5pG4YC1cx0MJmkVMKnaKg_OAEJnzsW7Y-5-zr9W5KXfEUccR5iwfKl3vrXaGP1fqDura-8f4PsjjHNmnnHo9zPtYD70WvUPFfSlgl73fyoo-s0pdg07TI_2tPMC3p4AcIRxmGGKxI-urRvXdbY4fXSBMkfCssmBIvzz8d86MKIM</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>Boi, F</creator><creator>Lai, M L</creator><creator>Marziani, B</creator><creator>Minerba, L</creator><creator>Faa, G</creator><creator>Mariotti, S</creator><general>European Society of Endocrinology</general><general>Portland Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20051101</creationdate><title>High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies</title><author>Boi, F ; Lai, M L ; Marziani, B ; Minerba, L ; Faa, G ; Mariotti, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b456t-9d0c3b879be88dc1abc0a8dd74cb48060550efe2669af3d10bed02408a63aea93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Autoantibodies - blood</topic><topic>Biological and medical sciences</topic><topic>Clinical Studies</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Thyroid Gland - immunology</topic><topic>Thyroid Neoplasms - etiology</topic><topic>Thyroid Nodule - complications</topic><topic>Thyroid Nodule - diagnostic imaging</topic><topic>Thyroid Nodule - immunology</topic><topic>Thyroid Nodule - pathology</topic><topic>Thyroid. Thyroid axis (diseases)</topic><topic>Ultrasonography</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boi, F</creatorcontrib><creatorcontrib>Lai, M L</creatorcontrib><creatorcontrib>Marziani, B</creatorcontrib><creatorcontrib>Minerba, L</creatorcontrib><creatorcontrib>Faa, G</creatorcontrib><creatorcontrib>Mariotti, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boi, F</au><au>Lai, M L</au><au>Marziani, B</au><au>Minerba, L</au><au>Faa, G</au><au>Mariotti, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies</atitle><jtitle>European journal of endocrinology</jtitle><addtitle>eur j endocrinol</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>153</volume><issue>5</issue><spage>637</spage><epage>642</epage><pages>637-642</pages><issn>0804-4643</issn><eissn>1479-683X</eissn><abstract>Objective: We assessed the association between thyroid autoimmunity and thyroid cancer in a retrospective series of unselected thyroid nodules submitted to fine-needle aspiration cytology (FNAC) to avoid the selection bias of surgical series. Subjects and methods: Ultrasound (US)-guided FNACs were obtained from 590 unselected consecutive patients with single thyroid nodules and positive (ATA + , n = 197) or negative (ATA − , n = 393) serum anti-thyroid antibody (ATA). Cytological results were classified in three classes of increased risk of malignancy: low risk or benign (class II); indeterminate risk (class III); and suspect or malignant (class IV). Results: A higher prevalence of class III (28.9% vs 21.4%, P &lt; 0.05) and class IV (18.8% vs 9.2%, P &lt; 0.001) and lower prevalence of class II (52.3% vs 69.5%, P &lt; 0.001) were found in ATA + vs ATA − nodules respectively. By multivariate logistic regression analysis ATA + conferred a significant risk (odds ratio (OR): 2.29 (95% confidence interval (CI): 1.39–3.76)) for class IV cytology independently from age and sex. In 106 patients where thyroidectomy was carried out, thyroid cancer was found in 54/61 (88.5%) patients with class IV nodules (with similar positive predictive value for cancer in ATA + (96.4%) and ATA– (81.8%) nodules), in 6/31 (19.3%) of class III nodules (all ATA − ) and in none of 14 class II nodules. Non-specific cytological atypias from hyperplastic nodules in lymphocytic thyroiditis probably accounted for the different prevalence of cancer in class III ATA + and ATA − nodules. Histologically proven thyroid cancer (mostly papillary) was then observed in a higher proportion (27/197 = 13.7%) of ATA + , when compared with ATA − nodules (33/393 = 8.4%, P = 0.044), but the significance of this finding is limited by the low number of class II nodules operated on. Conclusions: The presence of ATA + confers an increased risk of suspicious or malignant cytology in unselected thyroid nodules. Since ATA + is not responsible for increased false- positive class IV FNAC, our study provides indirect evidence supporting a significant association between thyroid carcinoma and thyroid autoimmunity, although further studies with a different design are needed for a definitive histological proof.</abstract><cop>Colchester</cop><pub>European Society of Endocrinology</pub><pmid>16260421</pmid><doi>10.1530/eje.1.02020</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0804-4643
ispartof European journal of endocrinology, 2005-11, Vol.153 (5), p.637-642
issn 0804-4643
1479-683X
language eng
recordid cdi_proquest_miscellaneous_68741331
source MEDLINE; Oxford Academic Journals (OUP)
subjects Adult
Aged
Aged, 80 and over
Autoantibodies - blood
Biological and medical sciences
Clinical Studies
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Humans
Male
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Retrospective Studies
Risk Assessment
Thyroid Gland - immunology
Thyroid Neoplasms - etiology
Thyroid Nodule - complications
Thyroid Nodule - diagnostic imaging
Thyroid Nodule - immunology
Thyroid Nodule - pathology
Thyroid. Thyroid axis (diseases)
Ultrasonography
Vertebrates: endocrinology
title High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A43%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20suspicious%20cytology%20in%20thyroid%20nodules%20associated%20with%20positive%20thyroid%20autoantibodies&rft.jtitle=European%20journal%20of%20endocrinology&rft.au=Boi,%20F&rft.date=2005-11-01&rft.volume=153&rft.issue=5&rft.spage=637&rft.epage=642&rft.pages=637-642&rft.issn=0804-4643&rft.eissn=1479-683X&rft_id=info:doi/10.1530/eje.1.02020&rft_dat=%3Cproquest_cross%3E68741331%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19412881&rft_id=info:pmid/16260421&rfr_iscdi=true